Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Peginterferon

Hoofnagle JH, Seeff LB (2006) Peginterferon and ribavirin for chronic hepatitis C. New Engl J Med 355 2444-2451... [Pg.23]

Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C a randomised trial. Lancet 358 958-965... [Pg.23]

Forestier N, Reesink HW, Weegink CJ, McNair L, Kieffer TL, Chu HM, Purdy S, Jansen PL, Zeuzem S (2007) Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C. Hepatology 46 640-648... [Pg.104]

Jacobson IM, Everson GT, Gordon SC, Kauffman R, McNair L, Muir A, McHutchison JG (2007) Interim analysis results from a phase 2 study of telaprevir with peginterferon alfa-2A and ribavirin in treatment-naive subjects with hepatitis C. AASLD 58th Annual Meet, Abstract 177 Johnson M (2006) Response to Atazanavir/ritonavir versus lopinavir/ritonavir equivalent or different efficacy profiles by HUl. AIDS 20 1987... [Pg.105]

Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, Pham BN, Maylin S, Bedossa P, Deny P, MarcelUn P, Gault E (2006) Efficacy of peginterferon alpha-2b in chrome hepatitis delta relevance of quantitative RT-PCR for follow-up. Hepatology 44 728-735... [Pg.231]

Fried MW, Shiftman ML, Reddy KR, Smith C, Marinos G, Goncales EL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 975-982... [Pg.233]

Lindahl K, Stable L, Bruchfeld A, Schvarcz R (2005) High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C. Hepatology 41 275-279... [Pg.237]

Today, ISOpg of peginterferon-a2a once weekly for 48 weeks is recommended in patients with compensated liver disease. However, treatment schedules mat were chosen in clinical trials vary between 24 weeks to 2 years and optimal treatment durations and dose remain to be defined. [Pg.323]

At present, two types of peginterferon-a are approved for the treatment of chronic hepatitis C peginterferon-a2a and peginterferon-a2b, which differ in size and form of the linked polyethylene glycol molecule (40 vs. 12kDa). Both pegin-terferons are injected subcutaneously once a week (see chapter by Chevaliez and Pawlotsky, this volume, for further details). [Pg.328]

Patients infected with HCV genotype 1,4, 5 or 6 are treated with peginterferon-a in combination with ribavirin for 48 weeks (Table 3). In the pivotal trials, sustained virologic response rates achieved with patients infected with these genotypes were 46-51% with peginterferon-a2a and ribavirin and 42-48% with peginterferon-a2b and ribavirin. Different baseline parameters (female gender, age <40 years, low body... [Pg.328]

Diago M, Hassanein T, Rodes J, Ackrill AM, Sedarati F (2004) Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin. Ann Intern Med 140(l) 72-73... [Pg.342]

Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351(15) 1521-1531 Lindahl K, Stable L, Bruchfeld A, Schvarcz R (2005) High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C. Hepatology 41(2) 275-279... [Pg.344]

See other pages where Peginterferon is mentioned: [Pg.22]    [Pg.110]    [Pg.231]    [Pg.232]    [Pg.233]    [Pg.234]    [Pg.234]    [Pg.235]    [Pg.236]    [Pg.237]    [Pg.237]    [Pg.237]    [Pg.240]    [Pg.240]    [Pg.323]    [Pg.323]    [Pg.326]    [Pg.329]    [Pg.329]    [Pg.329]    [Pg.329]    [Pg.329]    [Pg.329]    [Pg.330]    [Pg.332]    [Pg.332]    [Pg.333]    [Pg.333]    [Pg.341]    [Pg.341]    [Pg.342]    [Pg.342]    [Pg.343]    [Pg.343]    [Pg.344]    [Pg.344]    [Pg.345]    [Pg.345]    [Pg.345]   
See also in sourсe #XX -- [ Pg.359 ]

See also in sourсe #XX -- [ Pg.2 , Pg.45 ]

See also in sourсe #XX -- [ Pg.2 , Pg.21 ]

See also in sourсe #XX -- [ Pg.690 ]

See also in sourсe #XX -- [ Pg.138 ]

See also in sourсe #XX -- [ Pg.49 ]



SEARCH



Interferon Peginterferon alfa

Interferons peginterferon

PEGASYS (peginterferon alfa

Peginterferon alfa

Peginterferon alfa for hepatitis

Peginterferon alfa-2a

Peginterferon alpha

Ribavirin Peginterferon alfa

© 2024 chempedia.info